regenerative · clinical-trial
GHK-Cu
Tripeptídeo cobre-binding.
Status:clinical-trial
Updated:May 13, 2026
Contributors:2
Half-life
2 h
Routes
SC, topical
Typical dose
1000–3000 mcg
Mechanism of action
Ativa genes de reparo dérmico e síntese de colágeno.
Reported applications
- · skin regeneration
- · hair
Frequently asked
What is GHK-Cu?
Tripeptídeo cobre-binding.
What is the half-life of GHK-Cu?
Reference half-life: approximately 2 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing GHK-Cu?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.